FindTrial
Sign In

An In-situ Detection for MicroRNA

A New Detection Method for MicroRNA in Patients With Breast Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06529614
Enrollment
100
Registered
2024-07-31
Start date
2024-07-20
Completion date
2025-11-01
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

We designed a new in-site detection method for MicroRNA in the serum of patients with breast cancer.

Interventions

OTHERIn-situ detection for Micro-RNA

a new in-situ detection methods for Micro-RNA

Sponsors

Tongji Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy without serious diseases \-

Exclusion criteria

* situations that may affect the results

Design outcomes

Primary

MeasureTime frame
Sensitivity and specificity of test8 months

Countries

China

Contacts

Primary ContactLei Dou, Dr.
616732045@qq.com15171473498

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026